About US

 

Yabao Pharmaceutical Group is a leading specialty pharmaceutical company with fully integrated technology development, product development, manufacturing, and commercialization capabilities. We leveraged over 30 years of experience, as a generic pharmaceutical R&D and manufacturing company, to successfully transition into a growing, profitable, and technology driven proprietary branded pharmaceutical business.  
In order to further develop our international pharmaceutical market, Yabao Pharmaceutical Group invested 50 million USD to establish Yabao Pharmaceutical Co., Ltd. Beijing (Beijing Yabao), which is located in Beijing and integrated with drug R&D, production and marketing systems. Beijing Yabao is among the first domestic companies gain CFDA’s GMP (2010) approval for the solid dosage forms manufacturing in 2011. Also, Beijing Yabao is awarded as the Model Enterprise for Quality Control of Drug Products in Beijing in 2012. Beijing Yabao is currently holding two ANDAs of Meloxicam and Galantamine Hydrobromide Tablet. During August 12th to 16th, 2013, Beijing Yabao accepted US FDA’s on site inspection, on December 17th, 2013, Beijing Yabao received a US FDA’s acceptance letter indicating that Yabao’s manufacturing facility is in compliance with current good manufacturing practice (cGMP) requirements. Beijing Yabao mainly focuses on generic control release product pipeline as the long term development plan.  
Beijing Yabao’s production facility with manufacture capacity of 10 billion tablets/capsules per year was designed and established according to the cGMP requirements of FDA. With super qualified production equipments from Manesty, GEA, IWK, Quadro and advanced lab instruments from Waters (HPLC), Agilent (GC), Varian (IR/UV), and Distek (Dissolution), etc.. 
With the strategic partnership of cooperation with some pharmaceutical manufacture, R&D and consulting companies in the US, and business running of our local office (Yabao USA, Inc.) in Pennsylvania, Beijing Yabao welcome qualified US pharmaceutical companies to be our US or regional distribution partners.